Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Period	Milestone	Group	Participants
Overall Study	STARTED	Preladenant 2 mg	156
Overall Study	STARTED	Preladenant 5 mg	155
Overall Study	STARTED	Preladenant 10 mg	156
Overall Study	STARTED	Placebo	155
Overall Study	STARTED	Rasagiline 1 mg	156
Overall Study	Treated	Preladenant 2 mg	154
Overall Study	Treated	Preladenant 5 mg	153
Overall Study	Treated	Preladenant 10 mg	153
Overall Study	Treated	Placebo	155
Overall Study	Treated	Rasagiline 1 mg	154
Overall Study	COMPLETED	Preladenant 2 mg	134
Overall Study	COMPLETED	Preladenant 5 mg	130
Overall Study	COMPLETED	Preladenant 10 mg	136
Overall Study	COMPLETED	Placebo	134
Overall Study	COMPLETED	Rasagiline 1 mg	129
Overall Study	NOT COMPLETED	Preladenant 2 mg	22
Overall Study	NOT COMPLETED	Preladenant 5 mg	25
Overall Study	NOT COMPLETED	Preladenant 10 mg	20
Overall Study	NOT COMPLETED	Placebo	21
Overall Study	NOT COMPLETED	Rasagiline 1 mg	27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01155466/flow